Persisting neuropsychiatric symptoms, Alzheimer’s disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate

INTRODUCTION: Neuropsychiatric symptoms are important treatment targets in the management of dementia and can be present at very early clinical stages of neurodegenerative diseases. Increased cortisol has been reported in Alzheimer’s disease (AD) and has been associated with faster cognitive decline...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouanes, Sami, Rabl, Miriam, Clark, Christopher, Kirschbaum, Clemens, Popp, Julius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762003/
https://www.ncbi.nlm.nih.gov/pubmed/36529757
http://dx.doi.org/10.1186/s13195-022-01139-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762003/
https://www.ncbi.nlm.nih.gov/pubmed/36529757
http://dx.doi.org/10.1186/s13195-022-01139-9

Ejemplares similares